Abstract
The effect of mesodiencephalic modulation on the metabolism of carbohydrates and lipids, insulin and cortisol secretion, the severity of neurological disorders and pain syndrome has been studied in patients with diabetic polyneuropathy. It has been established that the addition of a standard therapeutic complex with MDM-therapy reduces the neurological symptoms of the disease and the severity of the pain syndrome by half, as well as significantly improves the insulin regulation of carbohydrate and lipid metabolism. It has been proven that MDM-therapy reduces the body’s insulin resistance, which makes it possible to recommend this physical factor for the treatment of diseases associated with metabolic syndrome. The hypothesis of the systemic nature of MDM-therapy and its effect on the formation of adaptive responses is considered.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
